Healthcare

IHH Healthcare profits up 28% to $57.42m in Q2

IHH Healthcare profits up 28% to $57.42m in Q2

Singapore and Malaysia’s EBITDA earnings grew 28% and 29%, respectively.

Chinese pharma sales to hit $268b by 2028: Fitch Solutions

The effects of regulatory change on the sales of patented medicine are expected to be mild.

Singapore telehealth firm inks deal with Vietnamese insurer

Bao Minh's customers can consult with a doctor on their phones.

Icon Group acquires Hong Kong oncology clinic SunTech Medical

It is keen to make inroads into the ageing city.

Sumitomo Dainippon Pharma to acquire 10% stake in Roivant for $3b

The pharma will assume ownership interests in five biopharma companies.

Childhood vaccination in Singapore to be subsidised in CHAS general practitioner clinics

Subsidies will available in both polyclinics and CHAS clinics by end-2020.

Singapore medical device output grew 4.2% in June

The industry outperformed the output of the manufacturing sector, which fell 6.9%.

94% of Singapore firms attach international medical plans to healthcare programmes

This comes as employees seek more comprehensive plans to reduce out-of-pocket costs.

VC-sourced healthcare funding in Asia fell 39% to $2.57b in Q2

China-based Weimai’s $155m funding round was one of the quarter’s notable deals.

China healthtech funding crashed 49% to $1.92b in H1

The number of deals fell to 62 transactions in the same period.

India's healthtech deal value nearly doubled to $355m in H1

Investments in the wellness category ballooned to $155m.

Singapore clinched $145.78m of healthtech deals in 2018

The city trails only behind China and India in terms of deal value.

Asian healthtech deals hit $2.5b

$595m went to firms geared towards health management solutions.

The chatbot will see you now – virtual HCP engagement in the Asia Pacific

There is little doubt that the Asia Pacific region represents a key growth ambition for the majority of Life Sciences companies. Statistics around...

Cell therapy in the Asia Pacific — solution to the cancer challenge?

Over the next decade, an estimated $2t investment into Universal Health Coverage (UHC) schemes is expected to land in Asia. The developing markets in...

IT budgets could shrink for half of life sciences firms

Only 15% of life sciences firms believe digital tools could enhance customer experience.

Cheaper cell therapy gains ground in Australia, China, and Japan

In China, 80% of CAR-T trials are already being conducted by hospitals.